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Background: Presumptive treatment of childhood-malaria (PTCM) is common in Nigeria. Delayed laboratory result
is blamed, with little attention on patients’ and providers’ roles. This study aimed to determine patient, provider and
laboratory attributes that sustain PTCM in Nigeria.
Methods: Data collection was from focus-group discussions for parents/guardians, and in-depth interviews involving
providers and laboratory scientists in two tertiary hospitals.
Results: All parents/guardians agreed to a malaria test. Majority accepted to come back later for full treatment, provided
that some treatment was commenced. Majority affirmed that their interests are on their children’s improvement.
The providers practice presumptive treatment of childhood malaria, for the following reasons: (1) malaria is endemic and
should be suspected and treated; (2) microscopy takes two days to be available and parents want immediate treatment
for their children, thus delay may lead to self-medication; (3) relying on results for decision to treat creates an impression
of incompetence; (4) rapid diagnostic test kits (RDTs) are not available in the consulting rooms and there is doubt about
their reliability; (5) patients have already wasted time before being reviewed, so wasting more time on investigation is
not advisable; (6) withhold of malaria treatment may be feasible in suspected uncomplicated malaria, but if severe, then
anti-malarial treatment has to start immediately.
Interviews of laboratory scientists showed that (1) malaria microscopy test cannot be urgent; it is done in batches and
takes 24 hours to be ready; (2) a request of malaria test with other investigations on the same form, contributes to the
delay; (3) RDTs are unavailable in the facilities.
Conclusions: Provision of RDTs is the only feasible means to treatment of confirmed malaria at the time healthcare
providers review a patient on day zero. In facilities that depend on microscopy; a common practice in resource poor
countries, healthcare providers can depend on parental willingness to return later for full medication, to commence
adjunctive care with antipyretics and multivitamins for uncomplicated malaria. In complicated malaria, supportive
care - intravenous fluids, blood transfusion, oxygen therapy - can be commenced while awaiting the inclusion of
anti-malarial drugs when the diagnosis of malaria is confirmed.
Keywords: Presumptive treatment, Childhood malaria, Tertiary hospitals, Nigeria* Correspondence: kakatitis@yahoo.co.uk
1Department of Paediatrics, University of Nigeria Enugu Campus, Enugu, Nigeria
2Health Policy Research Group, University of Nigeria Teaching Hospital,
Enugu, Nigeria
Full list of author information is available at the end of the article
© 2013 Ughasoro et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Ughasoro et al. Malaria Journal 2013, 12:436 Page 2 of 9
http://www.malariajournal.com/content/12/1/436Background
In April 2000, the Roll Back Malaria (RBM) programme
was launched in Abuja, Nigeria with the sole aim of
reducing the burden of malaria in sub-Saharan Africa
[1]. One of its strategies is early diagnosis and treatment
of malaria [2]. Due to high prevalence of malaria in these
areas, and its associated high mortality in children, it was
advocated that an anti-malarial can be given based on
the presence of fever [3]. Another reason for this is the
anticipated high mortality that will occur especially in
children if anti-malarial therapy is delayed for malaria test
results to be available, the problem of lack of laboratory
support is expected more in the primary health care
facilities. Furthermore, it was argued that since the
prevalence of malaria was high in most sub-Saharan
regions, and first tier facilities are amongst the first
source of care for the patients, presumptive treatment
will be cost-effective if practiced there [4]. Studies have
shown that if 70% or more of fever cases are malaria
fever, presumptive treatment is more cost-effective than
prior microscopy or rapid diagnostic test (RDT) when
artemisinin-based combination therapy is the anti-malarial
in usage [5,6].
It is 13 years since the introduction of RBM programmes
in sub-Saharan Africa. Studies have shown a decline in
the burden of malaria in these endemic areas [7,8], with
a concomitant reduction in the proportions of fever
that can be attributed to malaria. This was supported
by a report by Tagbo et al. [9] where they documented
positive malaria parasitaemia of 29.2% amongst children
with history of fever in a tertiary clinic. Also, advance-
ments have been made in the area of malaria diagnosis
with the introduction of simple and easy to apply malaria
RDT kits [10,11]. Presumptive diagnosis and treatment
of malaria is still being practiced not only in the primary
health care facilities, but also in the tertiary hospitals
[12-14]. Considering the prevailing statistics, continued
practice of presumptive treatment will not only lead to
over-diagnosis of malaria, but also a lot of missed diagnosis
of other illnesses that have both immediate and long-
term morbidity and mortality. Other benefits of laboratory-
confirmed diagnosis and treatment of malaria in children
are: reduction of drug wastage, avoidance of adverse
drug events, and evasion of imminent loss of confidence
in anti-malarial drugs by the public due to use of anti-
malarial in cases that are not malaria cases.
The current guideline, has changed its stand on pre-
sumptive treatment of all childhood fever in sub-Saharan
regions with anti-malarial drugs [15], the global reduction
of malaria and the introduction and deployment of
malaria rapid diagnostic test kits (RDTs) to health facilities
has made the practice of presumptive treatment less
fashionable particularly in tertiary hospitals, where most
patients are likely to have received some form of self-medication before presenting, which almost always
includes an anti-malarial [16]. The doubt about the
adequacy of the dosage of medication administered is
erased by the current innovation of clearly stating the
dosage in terms of weight and age on the packet of the
drugs by pharmaceutical firms. In view of this, it is most
likely that adequate anti-malarial therapy had already been
taken before presenting to the health facility. Therefore,
presumptive practice in tertiary clinics is not permissible,
but various reports have continued to document a high
practice of presumptive treatment of malaria in tertiary
hospitals [12].
It is still surprising that even with the introduction
of RDTs, which are a good alternative to microscopy
[17,18], the expected improvement in the practice of
confirmation of malaria is not being reported. This gives
an insight that there may be more factors to presumptive
treatment of malaria than difficulties with microscopy
test for malaria. This study is aimed at determining the
perspectives of patients, health-care providers and labora-
tory scientists regarding the confirmation of malaria in a
tertiary hospital. The results might be useful in designing
appropriate interventions that will improve the practice




The study was conducted in two tertiary hospitals: University
of Nigeria Teaching Hospital, Enugu, and The Federal
Medical Center, Umuahia, both in southeast Nigeria. Both
hospitals are in the guinea-savanna forest region of Nigeria
where malaria transmission is stable all year round. The
two hospitals offer specialist medical care and also have
Residency training programmes in paediatrics.
Study design
The study was a qualitative, descriptive cross-sectional
study. The University of Nigeria Teaching Hospital,
Enugu and the Federal Medical Centre Umuahia, were
selected by simple random sampling from a sample
frame of four tertiary hospitals in Enugu and Abia
States.
In-depth interview (IDI): A list of all the residents and
consultants in each of the selected hospitals were com-
piled, as well as the laboratory scientists/technicians that
currently work in the unit that handles malaria test. Four
doctors and one laboratory scientist were randomly selected,
making a total of five interviewees for each centre.
Focus group discussion participants’ recruitment
Participants were recruited from parents/caregivers who
brought their children to the out-patient clinic. The
screener question was asked individually to select parents/
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Igbo language) and experience (a child or dependent treated
of malaria in a tertiary hospital within the preceding six
months). Potential participants were promised that their
children will be seen immediately after the focus group
discussion (FGD) to enhance their willingness to par-
ticipate and sustain their cooperation till the end of the
discussion.
Pilot focus group discussion and in-depth interview
The essence was to be sure that the responses to the
FGD and IDI guides yielded the relevant information. It
also helped to refine the questions and identified grey
areas that needed to be attended to. It also gave insight
to the likely time that each discussion will last.
Data collection methods
FGD and IDI guides were developed by a sociologist from
the recommendations of the research team and the guides
were reviewed. A four-item participant information form
consisting of age, sex, occupation, and education was
developed for the FGD. The participant information
form was administered before commencing the focus
group discussion and they filled their written responses.
Both the participant information form and the discussion
guide were written in English and then translated into
Igbo. The Igbo language guide was reviewed by native
Igbo speakers for clarity and easy understanding.
Focus groups
Four focus groups were conducted at the two study sites;
Federal Medical Center Umuahia and University of Nigeria
Teaching Hospital Enugu, between April 23 and May 3,
2013. The groups were purposive sampled to be gender
specific. All focus groups were conducted in Igbo language
and lasted approximately between 45 and 60 minutes. The
interviews were all tape recorded, notes taken and the tape
records were later transcribed.
In-depth interviews
In-depth interviews were with doctors and laboratory
scientists working in the two tertiary hospitals. The IDIs
were to find the opinions of medical professionals on
issues concerning malaria diagnosis. In total, 10 in-depth
interviews were conducted. Critical for IDI participant
selection included that the respondent should be managing
malaria cases. Purposive sampling was employed to select
in-depth interview respondents. This was done in order
to focus on people who have appropriate experience
and insight in malaria care. The questions for doctors
were divided into three topics with related sub-questions:
(i) malaria diagnosis; (ii) malaria treatment, and (iii)
follow-up. The questions for laboratory scientists were
concentrated around malaria tests and challenges.Data analysis
The transcription was first written down under each sub-
question and the commonly mentioned points were
highlighted. These form the reported quotes.
Ethical considerations
Ethical approval was obtained from the University of
Nigeria Teaching Hospital, Enugu, Ethical Health and
Research Committee. The aims of the study were explained
to all the participants and recorded verbal informed
consent were obtained before the interview started. The
recorded information was handled with confidentiality,
denying access to none research team members.
Results and discussion
Focus group discussion
Twenty-nine people participated in the four focus group
discussions. Out of this number, 17 (58.6%) were female
and 12 (41.4%) were male. The age range of the focus
group participants was 25 to 46 years. The majority of the
focus group participants were businessmen. The number
of years of schooling completed ranged from 3 to 17. See
also Table 1.
Focus group discussion results
Knowledge of malaria
The participants were very responsive to the question,
“What do you know about malaria and how a child with
malaria will present?” The majority responded that,
“Malaria is a major health problem in our country.” None
mentioned Plasmodium falciparum as the causative agent.
Several of them were able to mention common symptoms
of malaria. The most common mentioned symptoms were:
fever, weakness, poor appetite and vomiting. The following
are prominent responses:
“A child with malaria will have his head hot, when
you touch the body it will be very hot, especially the
head area.”
“I know that when a child has malaria, he will be very
weak, will like to lie down on the cold floor.”
“He will not eat; if you force him to eat, he will vomit
it, wants to be drinking only water.”
“The child will be weak, with joint pain, cold,
internal heat.”
Other illnesses that can present like malaria
There were quite few responses to the enquiry, “Are
there other illnesses that can present like malaria?” The
commonest amongst the responses was “typhoid” (enteric
fever). Others included “oyi” (pneumonia), “Iba ocha
n’anya” (hepatitis), and “cholera”.
Table 1 Demography of the participants





25 to 29 years 6 (20.7)
30 to 34 years 10 (34.5)
35 to 39 years 6 (20.7)
40 to 44 years 4 (13.8)
45 to 49 years 3 (10.3)
Occupation
Business 9 (31.0)





6 years or less 2 (06.9)
7 to 9 years 2 (06.9)
10 to 12 years 11(37.9)
14 years and above 14 (48.3)
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Self-medication was the most common response when
asked, “What will you do if you noticed that your child
has malaria?” They answered:
“I will go to chemist (patent medicine dealer) and
buy drugs.”
“Any time my child has fever, I will go to pharmacy
and ask them to mix drugs for me, multivitamins,
paracetamol and blood tonic. If after two days my
child is still ill, I will bring him to hospital.”
“Even if I will bring them to hospital, I will first give
them something to cool down the fever before coming
to the hospital. You know that children illness always
start in the night.”
Only one respondent did not accept the practice of
self-medication. “Anytime I notice that my children are
ill, I always take them to the hospital, children illnesses
are always serious so I don’t like wasting time trying to
treat them myself.”
Willingness to do malaria investigation if requested by a doctor
Majority want laboratory investigation to be done for their
children. When asked the question, “Which option will youchoose when you see a doctor, to treat your child without
investigation or do malaria test?” They answered:
“I will like the doctor to do malaria test for my child
to be sure of what is wrong with him.”
“Even if the doctor does not want to do malaria test, I
will request that he do the test. Since I have treated
my child at home and he did not respond. I will like
the doctor to investigate to be sure that it is still
malaria that is wrong with my child.”
“If the investigation will be available the same day, I
can wait, but to wait for 2–3 days without treatment,
I will not do that.”
“At times I will do the test before seeing a doctor, so
that he will know what is wrong with my child, and be
able to write the correct drug.”
“It is entirely the duty of a doctor to take charge of
management of my child’s illness. The request for
laboratory test or not, lies with the doctor. I am not
supposed to interfere.”
Willingness to wait for malaria investigation result before
receiving malaria treatment
When the participants were asked “Will you be willing
to wait for the malaria investigation result to be available
before starting your child on anti-malarial drugs?” They
were divided in their responses, although some said
outright “no,”
“How can I wait and watch my child dying, because I
am waiting for malaria test result that will be ready
in about 2 days’ time, I can’t do that, If the doctor
refuses to start my child on treatment, I will look for a
place where he will be treated.”
“It all depends, if my son’s illness is serious, the doctor
must start him on something while waiting for the
result, at least something to cool the fever.”
Others were of the opinion that if the doctor explains
and assured them that their children illnesses will not
worsen while waiting for the malaria investigation result
before commencing anti-malarial drug, they will wait.
“Since my child had received self- medication without
improvement before coming to this hospital. I have to
exercise patience if am asked to.”
“If the doctor tells me to take my child home and come
back another day for treatment, I will obey the doctor.
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with my child. But he must assure me that nothing
will happen to my child if I take him home.”
“A drug must be given, but if the doctor insists I will
obey him.”
“I will obey the doctor, this my daughter I brought to
hospital today, I brought her on Tuesday (two days ago)
and the doctor sent us to do test and to come back today
without any treatment, no paracetamol, no antimalarial,
nothing. I did as he instructed, today when I show him
the result he (doctor) will decide on treatment.”
“I will plead with the doctor to start treatment for my
child. If I go without treatment to come another day, I
will likely be seen by another who doesn’t know what
is wrong with my child and will start all over to ask
me questions.”
Whether their prescriptions/diagnosis were explained to them
The majority of the participants responded “no” when
asked, “Do you know the content of doctors’ prescriptions
for your child, or do doctors explain the prescription to
you?” Some of their specific comments included:
“Doctors do not tell people what is wrong with their
children and they always write their prescription such
that patients cannot read it.”
“Doctors never volunteer to explain their diagnosis.”
“I once asked, and the reply I got was, “If you know the
diagnosis of what importance is it to you.”
“I brought my child the other day to the hospital,
while I was in the hospital, my people (relatives) were
calling me to know what was wrong with him, but I
could not tell, since the doctor did not explain
anything to me. Only that my son was receiving
treatment and was getting better, that is all.”
“I am not bothered about what my child is on, once I
can notice improvement I am ok. I know the reason
why doctors write their prescription the way they do
but I won’t say it.”
“They do not inform patients about their illness.”
“Doctors’ prescriptions are always very difficult to read.”
In-depth interviews results/Doctors
The in-depth interviews enquired how you expect a
child with malaria to present.All the respondents accepted that malaria has different
and no specific symptoms and thus can mimic many
other illnesses. “Fever, vomiting, chills and refusal to eat
are the main symptoms and the common differential
diagnoses of malaria are; pneumonia, urinary tract infection,
acute gastro enteritis (AGE).” (Registrar, female, 5 years
of practice).
“Fever, joint pain, vomiting, headache (for children old
enough to complain), and malaise are the common
symptoms of malaria and acute respiratory tract
infection and urinary tract infection were the closet
differential diagnoses of malaria” (Consultant
Paediatrician, 15 years of practice).
How do you decide on malaria?
“Malaria is endemic so should be considered first”
(Registrar, female, 5 years of practice).” “Clinical
diagnosis is important because laboratory results are
not available the same day, thus the only reasonable
option is presumptive treatment” (Consultant
Paediatrician, 15 years of practice).
“Most parents that have treated their children but
with no improvement, will request for investigation,
but have never tried not starting medication due to
lack of result” (Consultant Paediatrician, 15 years
of practice).
“Mild cases can wait, but severe malaria cases always
request for treatment first” “Endemicity of malaria
makes it the first option to treat once suspected,”
(Registrar, male, 5 years of practice).
“I always assume that it is malaria and you cannot be
wrong. This is the tropics.” “Once I exclude other
systems, I will treat for malaria.” (Registrar, female,
6 years of practice).
World Health Organization (WHO) Recommendation of
confirmed malaria treatment
“Parental pressure to see improvement in their child’s
illness, compel doctors to act quickly to commence
treatment before getting results.” “Relying on laboratory
result before treatment will give the parents the
impression that the doctor is incompetent, thus there is a
high possibility of the patient to seek care from an
alternative source.” (Registrar, female, 5 years of practice).
“Rapid diagnostic test kits (RDTs) are not available in
the clinics to facilitate confirmation of malaria before
treatment.” “I may send for investigation, but I don’t
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(Registrar, male, 5 years of practice).
“Laboratory investigation has its drawback. It takes a
minimum of 48 hours to have results and the patient
before you needs attention. So why wait.” “Rapid
diagnostic kit is not used. Though RDT is available, we
do not use it. It was once tried and all the cases it was
tried on were negative. Some of the negative RDT tests
turned out positive when microscopy was done on
them. This raised a lot of doubt on RDT. So for RDT
to be used there is need for expertise.” (Registrar, male,
5 years of practice).
“I practice presumptive treatment most of the time.
Rapid diagnostic test is not available in the clinic.
Microscopy result will not be available till next day.
Remember, these patients must have waited for a long
time in the clinic before being seen by a doctor.
Causing them further delay because of test result, does
not go well with the patient.” (Senior Registrar, female,
9 years of practice).
“Siting of the hospital is not helping matters, most
caregivers will not readily accept to leave without
medication. They will always plead for medication.
More so, there is the issue of cost of their
transportation and inconveniences, if they are to
come back another day.” “Rapid diagnostic test kit is
available but only at the children emergency room,
which is located at the other extreme of the hospital,
there is none in this consulting area, thus I do
presumptive treatment based on clinical assessment.
I cannot rely on laboratory test.” (Registrar, male,
7 years of practice).
“It depends on my assessment of the patient; if acutely
ill, I will treat immediately but if an uncomplicated
case, it can wait for the test result. But since I cannot
guarantee who will come back. I am always tempted
to treat.” “Rapid diagnostic test kit is only available in
the emergency room, but we don’t normally send them
to emergency room to do the test.” (Registrar, female,
6 years of practice).
Explain prescription to patients
“I do but not always” (Registrar, female, 5 years
of practice).
“I do inform my patients on how to take their
medication.” “Sparingly due to busy clinic, but for
mothers that request, I always oblige them.” “No I
don’t.” (Registrar, male, 6 years of practice).In-depth interviews results/Laboratory scientists
According to most of the respondents, the laboratory is
being over-worked. No single unit handles only malaria
test. The shortest period malaria test can be ready is
after 24 hours, thus malaria microscopy test cannot be
done as urgent test. They also indicated that malaria
tests are done in batches, so even when a test is sent
early, it will not be started until a particular number
of other malaria tests are collected. Additionally, they
informed that rapid diagnostic test kits are not available
in the laboratories.
“The hematology unit that handles malaria test also
takes care of other investigations like complete blood
count, reticulocyte count, urgent hemoglobin
estimation and erythrocyte sedimentation rate.”
“The capacity of the unit in terms of staff strength does
not match with sample load.” “A minimum of about
70 samples out of which 50 may be for malaria test
are handled every day. Our target is to get all results
out within 24 hours. But due to logistics of records,
patients may not be able to access their results until
the second day”
Responding to whether malaria test can be done as an
urgent test, the respondents did not quite agree with that.
“Malaria test cannot be urgent. No matter how fast a
doctor wants it, the test has to pass through a
standard process which takes at least, three hours.”
“We run malaria test in batches, so even when a
request for malaria test comes early, it still has to wait
until a sizeable number of other malaria tests are
collected. One particular sample cannot be singled out
for investigation.”
“If a physician brings the test request and the sample
to the laboratory, it may attract specific attention, but
writing “treat as urgent” is not considered. Imagine
when virtually all investigations have “urgent” remark
on them, it is hard to make out which one is really
urgent.” “The habit of requesting for malaria test
along with hemoglobin estimation or full blood count
all in one form causes some delay. Because when the
sample arrives, it is first sorted out based on the test
options requested. So if only malaria test is requested
for in a form, it eases the delay. More so, it can be
sent directly to parasitology unit to handle and
pressure of work over there is lighter, although this
arrangement has not been fully worked out.” “No
malaria rapid test is done here, although it has been
recommended.”
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This study reported the perceptions of patients, doctors
and laboratory personnel regarding the different factors
that contribute to the presumptive treatment of malaria.
All the parent/caregiver respondents agreed that malaria
has many non-specific symptoms, which can also be
manifested by other disease entities. This is similar to
what was reported by other studies [19], where most of
the respondents were knowledgeable of symptoms of
malaria, as well as other illnesses that can present like
malaria. It was documented that virtually all the respon-
dents, except one had self-medication before presenting
at a tertiary hospital. This practice, on the background
of nonspecific symptoms of malaria means that parents
and caregivers are at liberty to use different types of
medication which may include anti-malarial drugs. This
is supported by different African studies that have reported
that about 90% of fever assumed to be malaria received
treatment at home Uzochukwu et al. [16], Thera et al.
[20], Fawole et al. [21], and Nyamongo et al. [22]. Their
decision to visit the hospital or clinic is taken when the
self-medication had failed to yield any appreciable effect.
The reasons can be either; inadequate anti-malarial ther-
apy or treating non-malaria illness with an anti-malarial.
The latter is more likely to be the case, considering that
since the introduction of ACT as the primary malaria
treatment, the most anti-malarial drugs are sold in their
packages with clear instructions and graphics on its
dosage with regards to weight and age. Therefore, the
adequacy of self-medication is to a greater extent guaran-
teed, compared to the era of chloroquine, sulphadoxine/
pyrimethamine (SP) whereby the patent medicine vendors
(PMV) purchased them in tins and later decided on the
dose considered appropriate for the child, coupled with
their poor knowledge of illness management [23]. In view
of the above, it is most likely that adequate anti-malarial
therapy should have been taken before presenting to
the health facility. The possibility of persistent fever being
malaria-related is less.
All the respondents were willing to do malaria test if
prescribed by the doctor. There were some that affirmed
that even if malaria test was not requested, they will ask
for it. One obvious reason for this is that most of the
respondents opt to use formal health care providers
when their self-medication had failed. Thus, at this
point they are very willing to know what is actually
wrong with their children. However, virtually all the
respondents would want their children to be started on
medication while awaiting the investigation result. This
may be because of the fact that an appreciable number
of the respondents showed confidence in the providers
and ready to comply with management plan, a disposition
that is borne out of the perception that doctors in
tertiary hospitals have higher level of formal trainingand experience [24]. Nonetheless, only one respondent
accepted to comply if doctors decided not to start
treating her child until investigation result is available.
The providers’ perceptions of patients’ expectation of a
prescription was the strongest predictor of their decision
to prescribe as noted by Britten et al. [25]. Although
patients want prescriptions, this need is based on their
anticipation of what will improve the health condition
of their sick child. Therefore, providers who still want
to practice laboratory - confirmed treatment of malaria
can institute symptomatic treatment with antipyretic,
haematinics, and multivitamins, for uncomplicated cases
on an out-patient basis until their malaria status is
established [26]. For patients with features of compli-
cated malaria, they can be admitted on supportive care
with blood transfusion, correction of hypoglycaemia,
anticonvulsants and fluid therapy, until malaria is con-
firmed and treated. It has been shown that the institution
of early intensive care reduces mortality in patients with
P. falciparum who did not show clinical response to
anti-malarial treatment within 48 hr [27], it therefore means
that with appropriate supportive care, commencement
of anti-malarial treatment can be delayed for a while or
rather till it is deemed fit. In this situation, the healthcare
provider can make a special request by accompanying
the blood sample to the laboratory for urgent and prompt
attention.
There is no doubt whether children being managed
on out-patient basis will return for further evaluation.
Since in this study, it was shown that respondents are
willing to return for the result of their tests and also for
addition of more medication at a later date, even if their
children have made remarkable improvement. Also, their
knowledge that other illnesses can mimic malaria is an
attribute that can be harnessed by health providers to
encourage parents and caregivers to wait for proper
evaluation before administrating anti-malarial therapy.
The practice of not explaining prescription to parents
that was complained about by most respondents in this
study should be discouraged. Rather Doctors should
make every effort to explain their management plan to
patients, so that in the event that their children improved
on supportive care, they would aspire to represent for final
decision. Explaining their treatment plan will immensely
enhance the parents’ knowledge about their health with
regards to their choice of self-medication.
In this study, presumptive treatment is commonly
practiced by all the providers. A finding similar to what
Hamer et al. [28] reported in their study. This undermines
the increasing body of evidence that greater percentage
of febrile patients do not have malaria, especially now
that studies from different localities indicate decline in
malaria prevalence, Tagbo et al. [9] and Reyburn et al.
[29]. Apart from the erroneous mindset that malaria is still
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that relying on laboratory result is a salient indicator of
incompetence on the part of the provider. What the
providers with such mind-set should realize is that most
respondents strongly support doing malaria test, especially
when being managed in a tertiary hospital. But what they
were reluctant to accept is delay in instituting treatment.
Since treatment is not synonymous with the use of an
anti-malarial, providers are at liberty to use their discretion
on how to handle individual child. Considering that malaria
test with microscopy takes time to be ready and RDTs are
not made readily available in the consulting rooms, it is im-
portance to device means through training and seminars
to constantly remind providers of the prevalence of posi-
tive malaria parasitaemia among children with fever.
In this study, report from the laboratory section made
it clear that the pressure of malaria test request exceeded
the capacity of the unit that handled malaria test, mainly
due to dependency on malaria microscopy, which cannot
adequately satisfy the daily malaria test requests. If this
remains the situation, it means that confirmation of mal-
aria on the same day of request depending on microscopy
is virtually impracticable in the tertiary hospital. On few
occasions, if the provider brings the test request physically
and makes a special request on it, will it be singled out
and processed. A privilege all malaria tests cannot enjoy.
Thus, the only practical means to confirmed treatment
of malaria on day zero is the deployment of RDTs to
clinics and encouraging providers to use and rely on the
results so obtained. There is need for proper storage of
these kits and their being used before the expiration date to
ensure their proper function, there is enormous evidence
about the sensitivity and specificity of RDTs for diagnosing
malaria [30,31]. Ironically, the lack of trust report by
some of the provider respondents that have used RDTs,
about the high negative results observed amongst children
with fever. Could the low yield of positive result observed
be evidence of the reported decline in positive malaria
parasitaemia amongst febrile children from most districts
where RBM is being implemented? [32].
Limitation of the study
The study was done in only two tertiary hospitals in
two different states. Although patients that visit the two
hospitals come from diverse ethnicity and socioeconomic
groups, the structure of the hospitals differ. Although
there is very high chance that the problem existing in
these two tertiary hospitals will be the same in other
hospitals, there is need to identify the peculiar problems
with the other hospitals in that region.
Conclusion
This study highlights that as long as the confirmation of
malaria in tertiary health facilities depends on microscopy,the practice of confirmed treatment of malaria on the
day of presentation will remain an illusion. Nonetheless,
providers can use their discretion to achieve some form of
confirmed treatment of malaria, even if it means delayed
inclusion of anti-malarial in the adjunctive therapy the
child is already started on. Try as much as possible to
explain their management plan to the parents, who
have shown willingness to adhere to it. Deployment of
RDT should be pursued, with quality control measures
to guarantee confidence in its results.
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